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Abstract
Background. Equations for estimating glomerular filtra-
tion rate (GFR) have not been validated in Sub-Saharan
African populations, and data on GFR are few.
Methods. GFR by creatinine clearance (Ccr) using 24-hour
urine collections and estimated GFR (eGFR) using the four-
variable Modification of Diet in Renal Disease (MDRD-4)
[creatinine calibrated to isotope dilution mass spectrometry
(IDMS) standard], Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) and Cockcroft–Gault equations
were obtained in Ghanaians aged 40–75. The population
comprised 1013 inhabitants in 12 villages; 944 provided a
serum creatinine and two 24-hour urines. The mean weight
was 54.4 kg; mean body mass index was 21.1 kg/m2.
Results. Mean GFR by Ccr was 84.1 ml/min/1.73 m2;
86.8% of participants had a GFR of ≥60 ml/min/
1.73 m2. Mean MDRD-4 eGFR was 102.3 ml/min/
1.73 m2 (difference vs. Ccr, 18.2: 95% CI: 16.8–19.5);
when the factor for black race was omitted, the value
(mean 84.6 ml/min/1.73 m2) was close to Ccr. Mean
CKD-EPI eGFR was 103.1 ml/min/1.73 m2, and 89.4 ml/
min/1.73 m2 when the factor for race was omitted. The
Cockcroft–Gault equation underestimated GFR compared
with Ccr by 9.4 ml/min/1.73 m2 (CI: 8.3–10.6); particularly
in older age groups. GFR by Ccr, and eGFR by MDRD-4,
CKD-EPI and Cockcroft–Gault showed falls with age:
MDRD-4 5.5, Ccr 7.7, CKD-EPI 8.8 and Cockcroft–Gault
11.0 ml/min/1.73 m2/10 years. The percentage of indivi-
duals identified with CKD stages 3–5 depended on the
method used: MDRD-4 1.6% (7.2 % without factor for
black race; CKD-EPI 1.7% (4.7% without factor for black
race), Ccr 13.2% and Cockcroft–Gault 21.0%.
Conclusions. Mean eGFR by both MDRD-4 and CKD-EPI
was considerably higher than GFR by Ccr and Cockcroft–
Gault, a difference that may be attributable to leanness.
MDRD-4 appeared to underestimate the fall in GFR with
age compared with the three other measurements; the fall
with CKD-EPI without the adjustment for racewas the clos-
est to that of Ccr. An equation tailored specifically to the
needs of the lean populations of Africa is urgently needed.
For the present, the CKD-EPI equation without the adjust-
ment for black race appears to be the most useful.
Keywords: CKD-EPI eGFR; Cockcroft–Gault eGFR; creatinine
clearance measurement; Ghana; MDRD-4 eGFR
Introduction
Chronic kidney disease (CKD) is a leading cause of morbid-
ity andmortality in both developed [1,2] and developing [2–
4] countries. While primary kidney disease is believed to
account for 1.2% of all deaths worldwide [5], many more
renal deaths are a consequence of hypertension and type
II diabetes mellitus [6,7]. In the countries of Sub-Saharan
Africa, facilities for the treatment of CKD are scanty, and
chronic dialysis is available in less than half of them. In
those countries that do offer transplantation and dialysis, on-
ly a small proportion of the population can afford the treat-
ment [8,9]. Hence, in developing countries, just as in
developed countries, detection of kidney disease and pre-
vention of its progression are of paramount importance.
For the people of Sub-Saharan Africa, early detection of
CKD, especially in high-risk groups such as hypertensives
and diabetics, is likely to be the most cost-effective strategy
[10]. An important first step in the assessment of CKD is
determination of glomerular filtration rate (GFR). Serum
creatinine as a surrogate marker is unreliable, and accurate
measurements using inulin, iothalamate or other radioiso-
topes are too expensive to be used for screening. Creati-
nine clearance (Ccr) is suff iciently accurate but the
required 24-hour urine collection too cumbersome and po-
tentially beset by pitfalls for studies in the community;
hence, the popularity of estimating GFR from equations
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using serum creatinine, in particular the Cockcroft–Gault
[11] and four-variable Modification of Diet in Renal Dis-
ease (MDRD-4) [12] equation. There is now a new equa-
tion [13]—the CKD-EPI—which is claimed to be as
accurate as the MDRD-4 for estimated GFR (eGFR)
<60 ml/min/1.73 m2, and ‘considerably more accurate’ than
MDRD-4 in the group with eGFR >60 ml/min/1.73 m2.
The 1013 individuals described in this paper are healthy
40–75 year old inhabitants of 12 communities in the Ashanti
region of Ghana. We have published demographic details of
the population [14] and data on the prevalence, detection,
treatment and control of hypertension [15]. We have now
studied the relationship between Ccr and three methods of
estimating GFR, namely the Cockcroft–Gault [11], MDRD-
4 [12] and CKD-EPI equations, to determine which method
would be of most use in our population, and similar popula-
tions elsewhere in Africa, in identifying individuals with
CKD. Unfortunately, none of the usual gold standards for
GFR measurement were available to us as a comparator.
Materials and methods
Population
The study was a cluster-randomised trial in 12 communities in the Ejisu-
Juabeng and Ashanti districts near Kumasi [14,15]. From each village,
participants aged 40 to 75 were selected using age- and gender-stratified
random sampling to ensure that participants from each village matched
overall population structure [14]. Individuals with serious mental or phys-
ical illness, women pregnant or lactating and individuals declining to par-
ticipate were excluded from the study. Individuals with hypertension,
diabetes or known renal disease were not excluded.
Questionnaire
Participants attended a registration centre in their village. After details of
the study had been explained in the local language (Twi), individual
written consent was obtained. All participants, with the help of a project
assistant, completed the questionnaire, which included sections on demo-
graphic background, socioeconomic status, health, diet, lifestyle and past
and current drug treatment. Ethical approval was granted by the Com-
mittee on Human Research Publication and Ethics of the School of Med-
ical Sciences, Kwame Nkrumah University of Science and Technology,
Kumasi, and by Wandsworth Research Ethics Committee, London.
Measurements
Height was measured to the nearest 0.5 cm using a wooden platform with
height rule; footwear was removed. Weight was measured to the nearest 0.5
kg with manual Seca 761 scales (Vogel & Halke, Hamburg, Germany) after
participants had removed outer garments and footwear. Body mass index
(BMI) was calculated from the equation: BMI = weight (kg) / height (m)2.
Blood pressure and pulse rate were measured with an automated sphygmo-
manometer (OMRONHEM705CP, OmronMatsusaka Co,Matsusaka City,
Mie-Ken, Japan) using appropriate cuff size after participants had sat un-
disturbed for at least 5 minutes. Three readings were taken 1 minute apart.
The first was discarded, and the mean of the last two used in the analysis.
Blood samples and 24-hour urine collections
Venous blood samples were taken fasting from each participant. The sam-
ples were put into Vacutainer tubes and transported without delay to Kom-
fo Anokye Teaching Hospital (KATH). The tubes were centrifuged at
1500 rpm for 10 minutes at room temperature, and the serum transferred
into 5-ml aliquot tubes, which were kept frozen at −20°C until analysed.
Serum and urine creatinine were measured using a Jaffe alkaline picrate
method (Beckman–Coulter). Our method has been validated against iso-
tope dilution mass spectrometry (IDMS) values for creatinine and gave
the following correlation: IDMS in μmole/l = (Beckman–Coulter value
− 5.94) / 0.994 [16]. The re-calculated creatinine values obtained were
used in the modified MDRD-4 and CKD-EPI equations traceable to
IDMS values to calculate the eGFR [17].
Two consecutive timed 24-hour urine collections were obtained from
each participant. Each collection was started by the participants emptying
their bladder, the time of voiding being recorded. A 4.5-litre plastic bottle
(containing thymol as preservative) was provided, and the participants in-
structed to collect into the bottle all urine voided. The 24-hour collections
were brought to the study centre the following morning. Each participant
was then asked to void for a last time into the bottle; the time of voiding
being recorded. The urine collectionswere retained by the study centre, and
each participant was given a new bottle for the second 24-hour urine col-
lection, which was brought to the study centre the next day. The urine sam-
ples were transported to KATH where, before storage, electronic scales
were used to measure (weigh) the 24-hour urine volume. Five 5-ml aliquots
of the urine samples were pipetted into tubes and frozen at −20°C until ana-
lysed for creatinine.
Calculations and staging of kidney function
After adjustment for the duration of the collection, Ccr was calculated in
millilitre per minute. The means of the two 24-hour calculations were
used in the analysis. For Ccr and for eGFR using the Cockcroft–Gault
equation, the results have been adjusted for body surface area (BSA).
The following equations were used to arrive at the eGFR:
MDRD-4 [12]
GFR (ml/min/1.73m2) = 175× {[plasma creatinine (μmol/l) / 88.4] −1.154} ×
age (years)−0.203 × 0.742 (if female) × 1.212 (if black)
CKD-EPI [13]
The CKD-EPI equation, expressed as a single equation, is: ‘GFR = 141 ×
min(Scr/k, 1)α × max(Scr / k, 1) −1.209 × 0.993Age × 1.018 (if female) ×
1.159 (if black), where Scr is serum creatinine, k is 0.7 for females and
0.9 for males, α is −0.329 for females and −0.411 for males, min in-
dicates the minimum of Scr/k or 1, and max indicates the maximum of
Scr/k or 1.’
Modified Cockcroft–Gault [11]
GFRðml=minÞ
Males =
1:23ð140−ageÞ  weightðkgÞ
plasmacreatinine ðμmol=lÞ
Females =
1:04ð140−ageÞ  weightðkgÞ
plasmacreatinine ðμmol=lÞ
The MDRD-4- and CKD-EPI-derived eGFRs are expressed as
ml/min/1.73 m2 because the equations were derived by comparison with
iothalamate-measured GFR, which itself is expressed as ml/min 1.73 m2.
Ccr and e-GFR derived by using the Cockcroft–Gault equation were con-
verted from ml/min to ml/min/1.73 m2 by multiplying calculated values
by 1.73, and dividing by BSA. Since the height and weight of each in-
dividual was known, it was possible to calculate the individual GFR as
ml/min/1.73 m2 for each participant.
Bodysurfacearea = 0:007184 height0:725  weight0:425½18
The correlations between radio-labelled iothalamate measured GFR,
and both MDRD-4 and CKD-EPI are close for individuals with GFR
<60 ml/min/1.73 m2 but less so for those with GFR >60 ml/min/1.73 m2.
aStages 1 and 2 are usually combined; they apply to patients with ev-
idence of kidney disease (other than reduced GFR), such as proteinuria,
haematuria and known kidney disease. In this paper, participants with
GFR >60 ml/min/1.73 m2 have been considered together.
Stages of chronic kidney disease [19]
Stage Clinical GFR (ml/min)
1a Normal >90
2a Mild impairment 60–89
3 Moderate impairment 30–59
4 Severe impairment 15–29
5 End-stage renal failure <15
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Statistical analyses
Results are presented as mean and standard deviation (SD). Males and fe-
males were compared using the t-test for continuous variables and by chi-
square for categorical variables. Differences in eGFR arrived at by the
MDRD-4, CKD-EPI and Cockcroft–Gault equations were compared with
Ccr using the paired t-test. Correlations between Ccr and eGFR were esti-
mated using Pearson's correlation coefficients and fall in GFR with age us-
ing linear regression. Limits of agreement between MDRD-4 (both with
andwithout the factor for black race) andCcr and betweenCockcroft–Gault
and Ccr were calculated using the Bland–Altman method [20].
Results
Serum creatinine values were available for 1007 of the
1013 participants, 944 (93.7%) of whom provided two
satisfactory 24-hour urine collections (coefficient of var-
iation; 17.7%) (Figure 1). Some samples had to be
excluded because of discrepancies in the creatinine ex-
cretion of the two samples. Table 1 shows some character-
istics of the participants who were lean, the mean body
weight being 54.4 kg with mean BMI 21.1 kg/m2. Diastol-
ic blood pressure was higher in the men; there was no sta-
tistically significant difference between men and women
as regards systolic pressure. Eight hundred eighty-eight
participants (94%) were from the same tribe (Ashanti),
and most were farmers (n = 629, 67%) or traders (n =
138, 15%).
Table 2 shows creatinine measurements, Ccr (ml/min
1.73 m2) and three estimates of GFR (MDRD-4,
CKD-EPI and Cockcroft–Gault). The mean Cockcroft–
Gault estimate of GFR was 9.4 (95% CI 8.3 to 10.6)
ml/min/1.73 m2 lower than the Ccr GFR. The mean
MDRD-4 and CKD-EPI eGFRs were higher than Ccr
GFR at 18.2 (16.8 to 19.5) and 19.0 (17.8 to 20.2)
ml/min/1.73 m2, respectively, and the discrepancy for
both equations was greater in the men than the women.
Figure 2 gives the distribution by CKD stage.
Figure 3 shows Bland–Altman plots for MDRD-4,
CKD-EPI and Cockcroft–Gault vs. Ccr. Limits of agree-
ment, given in Table 2, are narrower for the Cockcroft–
Gault equation than for either MDRD-4 or CKD-EPI
and for the women than the men.
Figure 4 gives mean values by 5-year age group for
Ccr, and Cockcroft–Gault, MDRD-4 and CKD-EPI
eGFR. With increasing age, all methods show a fall,
which was least with MDRD-4 eGFR (5.5 ml/min/
1.73 m2/10 years), and greatest with Cockcroft–Gault
eGFR (11.0 ml/min/1.73 m2/10 years); the fall for
CKD-EPI was 8.7 ml/min/1.73 m2/10 years and for Ccr
7.7 ml/min/1.73 m2/10 years (Table 3). The values for
Ccr and the Cockcroft–Gault equation are given both un-
adjusted and adjusted for BSA (Figure 4), and illustrate
the magnitude of the effect of adjusting for BSA.
The MDRD-4 and CKD-EPI equations comprise four
variables—age, gender, creatinine and White/African-
American racial group. Age, gender and creatinine are
unalterable objective markers. The adjustment for racial
group used in the MDRD-4 and CKD-EPI equations
may not be appropriate for rural African populations.
2,743 adults aged 40 to 75 years 
identified by census from 12 villages 
1,896 stratified random sample 
invited to take part 
1,013 agreed to take part and 
completed questionnaire 
1,007 blood samples analysed 
950 had satisfactory 24 hour urine 
collections x 2 
944 participants with both blood sample 
and complete 24 hour urine collections 
16,965 total population of 12 
villages 
Fig. 1. Recruitment of participants.
Table 1. Characteristics of the population
Men n = 355 Women n = 589 All n = 944
Men vs. women
P values
Age (years) 54.5 (10.7) 54.8 (11.5) 54.7 (11.2) 0.70
Height (cm) 166.8 (6.8) 156.7 (7.0) 160.5 (8.5) <0.001
Weight (kg) 56.4 (9.7) 53.2 (12.0) 54.4 (11.3) <0.001
BMI (kg/m2) 20.3 (3.1) 21.7 (4.7) 21.1 (4.2) <0.001
Systolic BP (mm Hg) 125.9 (24.1) 125.2 (27.1) 125.5 (26.0) 0.70
Diastolic BP (mm Hg) 75.7 (13.6) 73.6 (13.5) 74.4 (13.6) 0.022
Plasma glucose (mmol/l) 4.1 (1.6) 4.1 (1.0) 4.1 (1.3) 0.91
Current smoker n (%) 64 (18) 1 (0.2) 65 (7) <0.001
Regular drinkera n (%) 123 (35) 41 (7) 164 (17) <0.001
Diabetes n (%) 22 (6.2) 19 (3.2) 41 (4) 0.030
Means and (SD) are given.
aOnce a week or more.
2180 J.B. Eastwood et al.
We therefore tried removing the factor for racial group
(Table 2, Figure 5). Without this variable, the values
for MDRD-4 and CKD-EPI become much closer to
Ccr. Nevertheless, both equations seem to overestimate
GFR in the older men.
Table 4 shows the effect of removing the factor for race
on the absolute numbers of participants allocated to CKD
stages 3–5. The unmodified MDRD-4 identified only 15
individuals out of the 944 compared with 125 identified
using BSA-adjusted Ccr; when the factor for race was
omitted from the MDRD-4 equation, there were 70 indivi-
duals in stages 3–5. Comparable figures for CKD-EPI are
16 and (without the factor for race) 44.
Discussion
This is the first report on prevalence of reduced GFR in
a community study in Sub-Saharan Africa; it shows that,
in a Ghanaian village population it is possible to collect
reliable data on kidney function. GFR estimated using
the MDRD-4 and CKD-EPI equations were 18.2 and
19.0 ml/min/1.73 m2 higher respectively than the value
Table 2. Serum creatinine, urinary creatinine and GFR
Men n = 355 Women n = 589 All n = 944
Men vs. women
P values
Serum creatinine (μmol/l) 89.7 (18.3) 72.5 (13.3) 79.0 (17.4) <0.001
24-hour urinary creatinine (mmol) 9.8 (2.7) 7.6 (2.0) 8.4 (2.6) <0.001
Creatinine clearance 82.3 (22.4) 85.3 (22.7) 84.1 (22.6) 0.051
Estimated GFR (ml/min/1.73 m2)
Cockcroft–Gault 72.1 (15.6) 76.2 (20.0) 74.7 (18.6) 0.001
MDRD-4 104.7 (23.0) 100.9 (22.6) 102.3 (22.8) 0.014
MDRD-4 without correction for race 86.5 (19.0) 83.4 (18.6) 84.6 (18.8) 0.014
CKD-EPI 103.6 (18.2) 102.8 (19.0) 103.1 (18.7) 0.52
CKD-EPI without correction for race 89.6 (15.8) 89.2 (16.5) 89.4 (16.2) 0.73
Limits of agreement
Estimated GFR minus creatinine clearance (ml/min/1.73 m2)
Cockcroft–Gault −10.1 (−44.8 to 24.5) −9.0 (−44.6 to 26.6) −9.4 (−44.7 to 25.8) 0.36
MDRD-4 22.4 (−22.1 to 66.8) 15.6 (−23.6 to 54.8) 18.2 (−23.6 to 59.9) <0.001
MDRD-4 without correction for race 4.2 (−36.7 to 45.1) −1.9 (−38.4 to 34.6) 0.4 (−38.2 to 39.0) <0.001
CKD-EPI 21.3 (−17.4 to 60.0) 17.6 (−17.2 to 52.4) 19.0 (−17.9 to 53.8) 0.003
CKD-EPI without correction for race 7.3 (−30.2 to 44.8) 4.0 (−30.0 to 37.9) 5.2 (−30.2 to 40.7) 0.006
Means ± SD except for estimated GFR minus creatinine clearance where mean differences and limits of agreement are given.
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Fig. 2. Distribution of renal function by GFR stage.
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obtained by Ccr, and the difference was more marked in
the men, whereas mean GFR estimated using the Cock-
croft–Gault equation was 9.4 ml/min/1.73 m2 lower than
Ccr.
When the results were compared in 5-year age groups,
the eGFRs arrived at by MDRD-4 and CKD-EPI were con-
sistently higher than Ccr, particularly in older age groups,
while that produced by the Cockcroft–Gault equation was
consistently lower. Without the correction for race, MDRD
and CKD-EPI were much closer to Ccr (0.4 and 5.2 ml/
min/1.73 m2 higher) with the women showing the greater
difference.
In a study of another ethnically homogeneous healthy
population, Viktorsdottir et al. [21] reported data on
19,256 adults aged between 33 and 85. They compared
three measures of GFR—the MDRD-4 equation, the
Cockcroft–Gault equation and the reciprocal of plasma
creatinine. Using MDRD-4 and Cockcroft–Gault, the re-
sults were similar in the 34–39 and 40–44 age groups.
With increasing age, the 5-year group correlations di-
verged, showing a fall in GFR with age with both meth-
ods but greater with Cockcroft–Gault (ca. 10 ml/min/1.73
m2/10 years) than with MDRD-4 (7.2 ml/min/1.73 m2/10
years). In our study, the calculated values for MDRD-4
eGFR were higher than for Ccr (102.3 vs. 84.6 ml/min/
1.73 m2/10 years) and the fall in GFR per decade much
smaller than that of Ccr (5.5 vs. 7.7 ml/min/1.73 m2/10
years). Our figure for fall in Ccr with age is very close to
the findings of a study of 884 healthy men [22].
An example of GFR measurement in an ethnically ho-
mogeneous community in a developing country was re-
ported by Jafar et al. [23]. They studied 262 adults ≥40
years from the Pashtun ethnic subgroup in Karachi, and
found that 77 (29.9%) had reduced GFR as judged by a
BSA-adjusted Ccr of <60 ml/min/1.73 m2—compared
with 13.2% (125 out of 944) in our population. Their ur-
ban population had a higher prevalence of risk factors for
CKD than ours and was heavier (weight 64.7 vs. 54.4 kg;
BMI 24.9 vs. 21.1 kg/m2). Diabetes was more common
(10.7% vs. 4.3%) as was tobacco use (40.4% vs. 20.1%).
Another difference was that both Cockcroft–Gault and
MDRD-4 equations gave higher eGFRs than measured
Ccr. The authors mentioned the possibility of under-collec-
tion of 24-hour urines; also the relatively low urinary crea-
tinines compared with whites.
In the MDRD study [12], the MDRD-4 equation
was found to be accurate in predicting GFR for values
<60 ml/min/1.73 m2; our intention was to evaluate it in
rural African communities, and to determine the preva-
lence of stage 3–5 CKD.
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Fig. 3. Bland–Altman plots for GFR estimated by CKD-EPI, MDRD-4 and Cockcroft–Gault compared with creatinine clearance. Solid line represents
equality of the two measurements: dotted line, the mean observed difference, as in Table 2.
Table 3. Fall in GFR by decade
Men n = 355 Women n = 589 All n = 944
Creatinine clearance ml/min/1.73 m2 per 10 years −6.7 (−8.8 to −6.7) −8.3 (−9.7 to −6.8) −7.7 (−8.9 to −6.5)
Cockcroft-Gault ml/min/1.73 m2 per 10 years −9.4 (−10.6 to −8.2) −11.8 (−12.9 to −10.8) −11.0 (−11.8 to −10.2)
MDRD-4 ml/min/1.73 m2 per 10 years −3.8 (−6.0 to −1.6) −6.4 (−7.9 to −4.9) −5.5 (−6.8 to −4.3)
CKD-EPI ml/min/1.73 m2 per 10 years −7.5 (−9.1 to −5.9) −9.3 (−10.4 to −8.2) −8.7 (−9.6 to −7.7)
95% confidence intervals given in brackets.
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The MDRD-4 study [12] encompassed 1501 individuals
aged 40–90, and the Icelandic study [21] 19 256 indivi-
duals aged 33–85 (mean age: male 52.1 years, female
54.1). The CKD-EPI study [13] involved 16 032 indivi-
duals but few were elderly. While the age of the partici-
pants was not very different from our study (944
individuals, 40–75 years), the studies differ fundamentally
in two other areas. The mean body weight of the indivi-
duals in the MDRD-4 study [12] was 79.6 kg, in the
CKD-EPI study 82 kg and in the Icelandic study [21]
80.3 kg (men) and 66.5 kg (women); in our study, mean
body weights were 56.4 kg for men and 53.2 kg for wom-
en. The other difference was the ethnic breakdown
(MDRD-4 [12]: 13% black; CKD-EPI [13]: ‘few non-
white persons’, Icelandic [21] 0% black, our study 100%
black). In addition, the CKD-EPI sample was not commu-
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nity based and had a larger number of subjects with CKD
stages 3–5.
Strengths of the study
Our study is the first to provide GFR data in a sizeable
adult African rural community. The age of the participants
means that, as a group, they are likely to be at risk of CKD,
and information in such groups is lacking. Our participants
live in a geographical area within a 10-mile radius, and
population homogeneity is high (94% Ashanti). In the
same communities, we have published information on pop-
ulation characteristics [14], prevalence and detection of
high blood pressure [15], salt intake [24], body mass index
[25] and on our efforts to reduce salt intake and blood
pressure [26]. This paper adds important information on
the renal aspects.
The data were collected with scrupulous attention to de-
tail. The 24-hour urine collections especially needed super-
vision at the beginning and end of each collection so that
the time could be recorded reliably.
Weaknesses
Most importantly, it is unfortunate that, in this community
study in Africa, we were unable, because the methods in-
volve inulin infusion, iodine-labelled iothalamate or other
radioactive isotopes, to use a ‘Gold standard’ measurement
of GFR.
There were some difficulties with data collection.
Though 1007 of the 1013 participants provided a blood
sample, rather fewer [944 (93.2%)] provided two satis-
factory 24-hour urine collections. Errors in urine collec-
tion are always a possibility—especially under-collection;
in the study, however, the results obtained do not suggest
that there was this particular problem. Another more
general difficulty was calculation of age. Many of the
older men and women did not have birth certificates
so age was determined by reference to well-known na-
tional events [14]. In some cases, the age stated at ran-
domisation (provided by the participant) differed from
that given on entry to the study itself (sometimes ob-
tained from other family members); hence, there were
a small number of individuals outside the intended limits
of 40–75 years of age. Consistent underestimation of age
could lead to overestimation of eGFR using any of the
methods described here. Since this would have a greater
effect on Cockcroft–Gault than on MDRD-4, it is unlike-
ly that inaccuracy in estimating age would account for
the high values of eGFR we have observed when using
MDRD-4.
How is GFR best assessed in African populations?
Our data show that the Cockcroft–Gault equation underes-
timates GFR, and if used in populations similar to ours,
would significantly misclassify individuals as to CKD
stage. The unmodified MDRD-4 eGFR appears to be erro-
neously high in that the values for eGFR are much higher
than those obtained Ccr. These observations are not new. It
is known that MDRD-4 underestimates GFR in some po-
pulations [27], and also that gender, age and BMI can af-
fect the accuracy of predictive equations [28]. It has been
pointed out too in a study of the relationship between car-
diac risk factors and GFR that the conclusions reached de-
pend on which equation is chosen for estimating GFR [29].
In a study of 2095 non-black individuals, Froissart et al.
[30] in France found that the MDRD-4 and Cockcroft–
Gault equations, respectively, misclassified 29.2% and
32.4% of their participants.
Table 4. Stage of renal function according to method of assessing GFR
GFR
stage
MDRD-4 CKD-EPI
ml/min/1.73 m2 ml/min/1.73 m2 Creatinine clearance Cockcroft-Gault
Omitting
correction
for race
Omitting
correction
for race
ml/min/
1.73 m2 ml/min
ml/min/
1.73 m2 ml/min
n % n % n % n % n % n % n % n %
Males 1 269 75.8 139 39.2 280 78.9 189 53.2 123 34.7 99 27.9 38 10.7 34 9.6
2 80 22.5 195 54.9 68 19.2 151 42.5 179 50.4 183 51.5 244 68.7 201 56.6
n = 355 3 6 1.7 19 5.4 7 2 14 3.9 49 13.8 65 18.3 70 19.7 115 32.4
4 0 0 2 0.6 0 0 1 0.3 4 1.1 8 2.3 3 0.9 5 1.4
5 0 0 0 0 0 0 0 0 0 0 0 0 – – – –
Females 1 396 67.2 190 32.3 448 76.1 295 50.1 232 39.4 148 25.1 135 22.9 91 15.5
2 184 31.2 350 59.4 132 22.4 265 45 285 48.4 278 47.2 329 55.9 259 44
n = 589 3 9 1.5 47 8.0 9 1.5 29 4.9 71 12 157 26.7 122 20.7 230 39
4 0 0 2 0.3 0 0 0 0 1 0.2 6 1 3 0.5 9 1.5
5 0 0 0 0 0 0 0 0 – – – – – – – –
All 1 665 70.4 329 34.8 728 77.1 484 51.3 355 37.6 247 26.2 173 18.3 125 13. 2
2 264 28 545 57.7 200 21.2 416 44.1 464 49.2 461 48.8 573 60.7 460 48.7
n = 944 3 15 1.6 66 7.0 16 1.7 43 4.6 120 12.7 222 23.5 192 20.3 345 36.6
4 0 0 4 0.4 0 0 1 0.1 5 0.5 14 1.5 6 0.6 14 1.5
5 0 0 0 0 0 0 0 0 – – – – – – – –
All 3–5 15 1.6 70 7.4 16 1.7 44 4.7 125 13.2 236 25.3 198 21.0 359 38.0
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Our finding of MDRD-4-derived eGFR being higher
than GFR obtained by both Ccr and the Cockcroft–Gault
equation is in contrast to data of other authors who have
found it to be lower. An extrapolation of data from the pa-
per of Verhave et al. [29] suggests that the explanation
could be the leanness of our participants. These authors
studied 8592 individuals and found that mean GFRs (by
Ccr, Cockcroft–Gault and simplified MDRD) were in the
range 77.5–94.6 ml/min/1.73 m2, i.e. very similar to the
data presented by ourselves. Figure 1 of their paper reveals
that as body weight falls from 110 to 65 kg, the simplified
MDRD eGFR rises. The lowest mean weight given is 65
kg at which point the GFR by simplified MDRD has al-
most risen to that of Ccr, which hardly changes across
the weight range. From extrapolating the curves in the fi-
gure, it seems likely that if Verhave et al. [29] had had par-
ticipants weighing between 45 and 65 kg (as we did), the
curves would have crossed. In other words, their results
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would be very similar to the data presented by us, i.e. that
the highest GFRs would be found with MDRD-4, followed
by Ccr and lastly Cockcroft–Gault. These ideas are ampli-
fied in a further paper by Verhave et al. [31]. Some of the
shortcomings of the MDRD-4 equation probably also ap-
ply to the CKD-EPI equation—notwithstanding its better
performance—and Levey et al. [13] mention the question
of its validity in populations at the extremes of muscle
mass. Indeed, they state that ‘All creatinine-based equa-
tions should be used with caution in people with abnormal-
ly high or low muscle mass’. We suspect our participants
would be considered to be such people.
Clearly, it is impractical, in trying to identify individuals
with reduced GFR in a community setting, to expect them
to perform 24-hour urine collections. We suggest that, until
a more credible equation is devised, the CKD-EPI equation
is used but without using the factor for racial group, i.e.
removing the multiplier that is included because the pa-
tients are black. This is an adjustment that has been sug-
gested previously for a population of CKD patients in
Sub-Saharan Africa [32]. Figure 5 shows the result of this
modification on the MDRD-4 and CKD-EPI slopes in our
population. The angle of the slopes has not changed with
omission of the racial factor but both are now much closer
to the Ccr slope.
Implications
The importance of our study is that to date there are few data
on the prevalence of CKD in Sub-Saharan Africa. Such
studies are difficult to undertake, and there are few funding
sources. Nevertheless, two major risk factors for CKD—
high blood pressure and diabetes—are common. The prev-
alence of both is believed to be increasing so the prevalence
of CKD is likely to increase. The nephrological community
clearly has an opportunity to develop strategies for detecting
and preventing CKD in Africa. We suspect that a coherent,
deliverable mechanism for doing this would be welcomed
by health policymakers in Africa.
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Abstract
Background. Autosomal dominant polycystic kidney dis-
ease (ADPKD), a major cause of end-stage renal failure, re-
sults from genetic mutation of either polycystin-1 (Pkd1) or
polycystin-2 (Pkd2). In order to develop novel therapies to
treat the advancement of disease progression, numerous ro-
dent models of different genetic backgrounds are available
to study cyst development.
Methods. Here, a Pkd1-floxed inducible mouse model us-
ing the interferon responsive Mx1Cre-recombinase was uti-
lized to test the effect of the small molecule triptolide.
Relative to other Pkd1 inactivation models, cyst progression
in this neonatal to adult transition model is attenuated. Fol-
lowing the characterization of inducible cyst formation in
these mice, the development of kidney cysts from triptolide
or vehicle-treated animals was analysed.
Results. AlthoughPkd1 deletion on postnatal Days P10 and
P12 resulted in numerous cysts by P35, daily injections with
triptolide beginning on Day P16 significantly reduced the
total number of cysts per kidney, with a pronounced effect
on the number of microcysts and the overall cystic burden.
Additionally, renal function as assessed by blood urea nitro-
gen levels was also improved in triptolide-treated mice at
both the P22 and P35 time points. As the Pkd1flox/flox;
Mx1Cremodel has not been previously used for drug devel-
opment studies, the feasibility of a 6-month adult Pkd1 in-
activation study was also tested. While kidney cyst
formation was minimal and focal in nature, livers of these
Pkd1-deficient micewere severely cystic, enlarged and pale.
Conclusions. These results suggest that the Pkd1flox/flox;
Mx1Cremodel of ADPKD is amenable to short-term kidney
cyst formation drug studies; however, it may be problematic
for long-term therapeutic research where widespread liver
cysts and fibrosis could compromise drug metabolism.
Keywords: ADPKD; polycystic; triptolide
Introduction
Autosomal dominant polycystic kidney disease (ADPKD)
is characterized by the progressive formation and expan-
sion of fluid-filled kidney cysts ultimately leading to a
decline in kidney function and end-stage renal disease
(ESRD). A defect in the gene product of either Pkd1
(85% of all ADPKD cases) or Pkd2 (15% of cases) is
thought to result in a loss of calcium signalling in kidney
epithelial cells and a reversion to the proliferative pheno-
type [1,2]. There are numerous murine models of
ADPKD available with varying genetic backgrounds, in-
cluding several with Pkd1 deficiencies [3–9]. Those mod-
els utilizing inducible Pkd1 inactivation allow for the
study of rapid kidney cyst formation in neonates as well
as a delayed disease progression in adult mice [4,6,10], as
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